Genotype-dependent expression of the transmembrane isoform of CTLA-4 in FOXP3+ Tregs

被引：0
|
作者：
Esposito, L. [1 ]
Rainbow, K. M. [1 ]
Clark, J. [1 ]
Nutland, S. [1 ]
Todd, J. A. [1 ]
Wicker, L. S. [1 ]
机构：
[1] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge, England
来源：
IMMUNOLOGY | 2011年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [1] CTLA-4 control over Foxp3+ regulatory T cell function
    Wing, Kajsa
    Onishi, Yasushi
    Prieto-Martin, Paz
    Yamaguchi, Tomoyuki
    Miyara, Makoto
    Fehervari, Zoltan
    Nomura, Takashi
    Sakaguchi, Shimon
    SCIENCE, 2008, 322 (5899) : 271 - 275
  • [2] Low expressions of PD-L1 and CTLA-4 by induced CD4+CD25+ Foxp3+ Tregs in patients with SLE and their correlation with the disease activity
    Zhao, Ling
    Zhou, Xiaoyu
    Zhou, Xiaobin
    Wang, Huijuan
    Gu, Lei
    Ke, Yao
    Zhang, Miaojia
    Ji, Xiaohui
    Yang, Xiaofan
    CYTOKINE, 2020, 133
  • [3] Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
    Sharma, Anu
    Subudhi, Sumit K.
    Blando, Jorge
    Scutti, Jorge
    Vence, Luis
    Wargo, Jennifer
    Allison, James P.
    Ribas, Antoni
    Sharma, Padmanee
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1233 - 1238
  • [4] Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease
    Chikuma, Shunsuke
    Bluestone, Jeffrey A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (05) : 1285 - 1289
  • [5] FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors
    Porcellato, Ilaria
    Brachelente, Chiara
    Cappelli, Katia
    Menchetti, Laura
    Silvestri, Serenella
    Sforna, Monica
    Mecocci, Samanta
    Iussich, Selina
    Leonardi, Leonardo
    Mechelli, Luca
    VETERINARY PATHOLOGY, 2021, 58 (01) : 42 - 52
  • [6] Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter
    Ferrara, Roberto
    Susini, Sandrine
    Marabelle, Aurelien
    CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3468 - 3468
  • [7] Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response
    Sharma, Anu
    Subudhi, Sumit K.
    Blando, Jorge
    Vence, Luis
    Wargo, Jennifer
    Allison, James P.
    Ribas, Antoni
    Sharma, Padmanee
    CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3469 - 3470
  • [8] Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma
    Koike, Kazushige
    Dehari, Hironari
    Ogi, Kazuhiro
    Shimizu, Shota
    Nishiyama, Koyo
    Sonoda, Tomoko
    Sasaki, Takanori
    Sasaya, Takashi
    Tsuchihashi, Kei
    Hasegawa, Tadashi
    Torigoe, Toshihiko
    Hiratsuka, Hiroyoshi
    Miyazaki, Akihiro
    PLOS ONE, 2020, 15 (08):
  • [9] Elevated FOXP3 and CTLA-4 expression in recent onset type 1 diabetic children
    Pild, M.
    Cheramy, M.
    Ludvigsson, J.
    Casas, R.
    ACTA DIABETOLOGICA, 2007, 44 : S40 - S40
  • [10] CT60 genotype does not affect CTLA-4 isoform expression despite association to TID and AITD in northern Sweden
    Mayans, Sofia
    Lackovic, Kurt
    Nyholm, Caroline
    Lindgren, Petter
    Ruikka, Karin
    Eliasson, Mats
    Cilio, Corrado M.
    Holmberg, Dan
    BMC MEDICAL GENETICS, 2007, 8
12345